- Home
- FET vs RCKT Comparison
FET vs RCKT Comparison
Compare FET & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FET | RCKT |
|---|---|---|
| Founded | 2005 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 309.5M | 340.9M |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | FET | RCKT |
|---|---|---|
| Price | $31.07 | $3.44 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $29.12 |
| AVG Volume (30 Days) | 108.3K | ★ 2.1M |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $790,292,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.41 | $3,582.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.78 | $2.19 |
| 52 Week High | $33.06 | $15.00 |
Technical Indicators
Market Signals| Indicator | FET | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 58.38 | 55.63 |
| Support Level | $28.68 | $2.81 |
| Resistance Level | $31.08 | $3.07 |
| Average True Range (ATR) | 1.31 | 0.18 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 86.54 | 95.31 |
Price Performance
Historical ComparisonAbout FET Forum Energy Technologies Inc.
Forum Energy Technologies Inc is a products company, serving the oil, natural gas, industrial and renewable energy industries. The company designs, manufactures, and distributes products and engages in aftermarket parts supply and services that complement its product offering. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. It operates in two reporting segments, namely Drilling and Completions and Artificial Lift and Downhole. Revenue largely comes from Artificial Lift and Downhole segment.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.